Miro Sciences LtdASX: MSX

Introducing Miro Sciences Ltd - Presentation

· Issued by Miro Sciences Ltd via ASX

Filed with ASX · · 18 pages · English

Summary by 6ix AI

It highlights the significant unmet need in the Crohn's disease market and the potential for StemSmart™ to address patients who have exhausted current treatment options. The presentation also discusses the company's manufacturing readiness and plans for clinical supply at scale.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/introducing-miro-sciences-ltd-presentation-1

Release

ASX:MSX Formally NeuroScienti?c Biopharmaceuticals (ASX: NSB) StemSmart™ Advancing Towards a New 1 Treatment for Severe Crohn’s Disease November 2026 Miro Sciences Ltd ABN 13 102 832 995 Disclaimer Presentation Information Forward Looking Statements This presentation has been prepared by Miro...

Miro Sciences Ltd on 6ix

In the deck

Earlier from Miro Sciences

All Miro Sciences news releases